ABILITY DIABETES GLOBAL Trial accepted in The Lancet
-
Clinical Trials
CERC is proud to share that the ABILITY DIABETES GLOBAL Trial has been accepted for publication in The Lancet. Conducted under the leadership of Dr. Roxana Mehran, this study reflects a successful collaboration between Mount Sinai and CERC as CRO.
